MMT Funds is focused on investing in companies developing advanced materials in the fields of nanotechnology, polymer technologies, biomaterials, energy and environmental technologies, industrial chemistry, and novel crystals, with a special focus on Israeli and Israel-related companies (60-70%). MMT focuses on companies with applications in the life science, microelectronics and semiconductors, and medical device spaces.
MMT Fund I, established in 1998, was capitalized at $11 million and is fully invested in nine portfolio companies. MMT Fund II, established in 2000, was capitalized at $40 million and is currently invested in 14 portfolio companies, three of which are follow-on investments to MMT I.
In addition to having a material science innovation, the companies MMT invests in have to cater to large, high-growth markets.